CIK 1782539
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 81.80% | 18 |
| Unclassified | 8.86% | 3 |
| Life Sciences Tools & Services | 4.17% | 1 |
| Health Care Providers & Services | 2.66% | 1 |
| Software | 2.51% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | EVMN | Evommune, Inc. | Health Care | 27.32% |
| 2 | MPLT | MapLight Therapeutics, Inc. | Health Care | 16.28% |
| 3 | LBRX | LB PHARMACEUTICALS INC | Health Care | 12.82% |
| 4 | OCS | OCULIS HOLDING AG | Unclassified | 7.69% |
| 5 | INCY | INCYTE CORP | Health Care | 4.17% |
| 6 | ONC | BeOne Medicines Ltd. | Health Care | 3.85% |
| 7 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Health Care | 3.52% |
| 8 | CELC | Celcuity Inc. | Health Care | 2.66% |
| 9 | ASND | Ascendis Pharma A/S | Health Care | 2.57% |
| 10 | PCOR | PROCORE TECHNOLOGIES, INC. | Information Technology | 2.51% |
21/24 names classified · sector 91.1% of weight · industry 91.1% · mkt cap 86.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 91.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 11% of book weight classified — the grid is NOT representative of the whole book.
Classified: 10.5% of book weight (4/24 names) · unclassified 89.5%: EVMN, MPLT, LBRX, OCS, RYTM, CELC, ASND, PCOR, MDGL, KYMR +10 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | EVMNEVOMMUNE INC | 1,441,032 | $33M | 27.3% | HOLD |
| 2 | MPLTMAPLIGHT THERAPEUTICS INC | 971,253 | $20M | 16.3% | HOLD |
| 3 | LBRXLB PHARMACEUTICALS INC | 630,657 | $16M | 12.8% | ADD 110% |
| 4 | OCSOCULIS HOLDING AG | 350,745 | $9M | 7.7% | TRIM −32% |
| 5 | INCYINCYTE CORP | 53,742 | $5M | 4.2% | TRIM −9% |
| 6 | ONCBEONE MEDICINES LTD | 15,722 | $5M | 3.9% | HOLD |
| 7 | RYTMRHYTHM PHARMACEUTICALS INC | 49,120 | $4M | 3.5% | HOLD |
| 8 | CELCCELCUITY INC | 28,300 | $3M | 2.7% | NEW |
| 9 | ASNDASCENDIS PHARMA A/S | 13,600 | $3M | 2.6% | HOLD |
| 10 | PCORPROCORE TECHNOLOGIES INC | 53,299 | $3M | 2.5% | HOLD |
| 11 | MDGLMADRIGAL PHARMACEUTICALS INC | 5,672 | $3M | 2.4% | TRIM −52% |
| 12 | KYMRKYMERA THERAPEUTICS INC | 30,875 | $3M | 2.1% | HOLD |
| 13 | ACADACADIA PHARM | 102,984 | $2M | 1.9% | HOLD |
| 14 | HELPCYBIN INC | 460,000 | $2M | 1.8% | HOLD |
| 15 | ARGXARGENX SE | 2,800 | $2M | 1.7% | HOLD |
| 16 | RVMDREVOLUTION MEDICINES INC | 19,253 | $2M | 1.5% | HOLD |
| 17 | RXRXRECURSION PHARMACEUTICALS IN | 595,287 | $2M | 1.5% | HOLD |
| 18 | INSMINSMED INC | 6,580 | $1M | 0.9% | NEW |
| 19 | ETHAISHARES ETHEREUM TR | 50,549 | $800,191 | 0.7% | HOLD |
| 20 | HRMYHARMONY BIOSCIENCES HLDGS IN | 27,049 | $757,642 | 0.6% | HOLD |
| 21 | TRDAENTRADA THERAPEUTICS INC | 49,082 | $619,415 | 0.5% | HOLD |
| 22 | IBITISHARES BITCOIN TRUST ETF | 15,968 | $613,491 | 0.5% | HOLD |
| 23 | RANIRANI THERAPEUTICS HLDGS INC | 493,584 | $362,686 | 0.3% | HOLD |
| 24 | BOLTBOLT BIOTHERAPEUTICS INC | 29,250 | $118,170 | 0.1% | TRIM −50% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| EVMNEVOMMUNE INC | — | — | — | — | 1.4M | 1.4M | $33M |
| MPLTMAPLIGHT THERAPEUTICS INC | — | — | — | — | 971K | 971K | $20M |
| LBRXLB PHARMACEUTICALS INC | — | — | — | 300K | 300K | 631K | $16M |
| OCSOCULIS HOLDING AG | 436K | 515K | 515K | 515K | 515K | 351K | $9M |
| INCYINCYTE CORP | 67K | 59K | 59K | 59K | 59K | 54K | $5M |
| ONCBEONE MEDICINES LTD | 20K | 16K | 16K | 16K | 16K | 16K | $5M |
| RYTMRHYTHM PHARMACEUTICALS INC | 49K | 49K | 49K | 49K | 49K | 49K | $4M |
| CELCCELCUITY INC | — | — | — | — | — | 28K | $3M |
| ASNDASCENDIS PHARMA A/S | 14K | 14K | 14K | 14K | 14K | 14K | $3M |
| PCORPROCORE TECHNOLOGIES INC | — | — | — | — | 53K | 53K | $3M |
| MDGLMADRIGAL PHARMACEUTICALS INC | 11K | 12K | 12K | 12K | 12K | 6K | $3M |
| KYMRKYMERA THERAPEUTICS INC | 31K | 31K | 31K | 31K | 31K | 31K | $3M |
| ACADACADIA PHARM | 103K | 103K | 103K | 103K | 103K | 103K | $2M |
| HELPCYBIN INC | — | — | — | — | 460K | 460K | $2M |
| ARGXARGENX SE | 430 | 3K | 3K | 3K | 3K | 3K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
